by telrheum | May 25, 2024 | Spondyloarthritis, Biologic Therapy
Anti-IL-17 Drugs: A Guide Interleukin-17 (IL-17) is a protein that plays a crucial role in the body’s immune response. While it’s important for fighting infections, too much IL-17 can lead to inflammation and various autoimmune diseases, such as psoriasis, psoriatic...
by telrheum | May 25, 2024 | Interstitial Lung Disease, JAK Inhibitor, Systemic Sclerosis
This study explored the effectiveness and safety of nintedanib (NTB), a drug approved for progressive fibrosing interstitial lung disease (PF-ILD), in combination with immunosuppressive agents (IS) for treating connective tissue disease-associated PF-ILD (CTD-PF-ILD)....
by telrheum | May 25, 2024 | IgG4-Related Diseases, Low Complements
Background IgG4-related disease (IgG4-RD) is an autoimmune condition that can affect various organs. Some patients with IgG4-RD have low levels of complement proteins in their blood. This study aimed to compare the characteristics and disease activity of IgG4-RD...
by telrheum | May 21, 2024 | Uncategorized
Researchers at the University of Kentucky studied whether Paxlovid, an antiviral drug, can help prevent hospitalizations and deaths due to COVID-19 in people with rheumatological diseases like rheumatoid arthritis. These diseases often require treatments that suppress...
by telrheum | May 19, 2024 | Autoimmune Diseases, Biologic Therapy, Pneumocystis Jirovecii
This systematic review and meta-analysis led by Athanasios Vassilopoulos and colleagues focuses on the effectiveness of prophylactic Trimethoprim-Sulfamethoxazole (TMP/SMX) in preventing Pneumocystis Jirovecii Pneumonia (PJP) among patients with Autoimmune...
